Nicaragua

ViiV Healthcare Access to ARVs

In the Least Developed Countries and sub-Saharan Africa GlaxoSmithKline has offered its HIV/AIDS medicines at not-for-profit (nfp) prices since 2001. ViiV Healthcare will maintain this commitment, and will include the additional products in its portfolio. All of ViiV Healthcare's ARVs are now available at not-for-profit prices to public sector customers and not-for-profit organizations in all Least Developed Countries and all of sub-Saharan Africa - 64 countries in total.

Sanofi-aventis: Diabetes Prevention

In 2006, sanofi-aventis launched pilot programs to help improve diabetes disease management in developing countries, in conjunction with the NGO Handicap International, Sante Diabete Mali and other local NGOs in Africa, Asia and Latin America. Several projects were set up in 2007 in Burundi, India, Kenya, Madagascar, Nicaragua, Philippines and Thailand. The program aims to help local health care systems to manage the disease better, prevent the onset of complications and so avoid the subsequent need for surgical interventions such as amputation.

Rotavirus Vaccine Program

The Rotavirus Vaccine Program works to accelerate the introduction of new vaccines to treat rotavirus.

Leprosy Elimination

Novartis is providing free treatment for leprosy patients worldwide through its multi-drug therapy.

HPV Vaccine & Cervical Cancer

Cervical cancer is the second most common cancer in women worldwide, with about 500,000 new cases and 250,000 deaths occurring each year. Almost 80% of cases occur in low-income countries, where cervical cancer is the number one cause of cancer in women. Virtually all cervical cancer cases (99%) are linked to genital infection with human papillomavirus (HPV), a family of virus types which also causes genital warts and other forms of cancer.

Global Pharma Health Fund

The Global Pharma Health Fund e.V. (GPHF) is a charitable organization initiated and funded exclusively by donations from Merck KGaA, Darmstadt Germany. In 2007, it took over the work of the former German Pharma Health Fund, which was set up in 1985. The organization aims to improve health care in the context of development assistance, in particular the use of the GPHF-Minilab in the fight against counterfeit drugs.

GlaxoSmithKline's PHASE Program

GlaxoSmithKline's Personal Hygiene & Sanitation Education (PHASE) project is helping to reduce diarrhea-related disease by encouraging school children to wash their hands. GSK established PHASE in 1998 and has so far invested over USD 7 million in the program. PHASE is run in partnership with AMREF, Save the Children and Earth Institute at Columbia University, as well as national Ministries of Health and Education in countries where the program is active. The program has had impressive results so far.

GAVI Alliance

The GAVI Alliance is a community of pharmaceutical companies seeking to reduce childhood morbidity.

Children Without Worms

Children Without Worms (CWW) is a partnership between Johnson & Johnson and the Task Force for Child Survival and Development that supports global efforts to reduce soil-transmitted helminth (STH) infections (intestinal worms) in children. Operating through partnerships with governments, communities, and NGOs, CWW seeks to treat 25 million children twice a year, as part of a larger campaign to increase awareness of STH, hygiene education, and the need for improved sanitation infrastructure and access to clean water.

Bayer HealthCare: Fight Against Chagas Disease

In April 2007, Bayer signed a new agreement to provide the World Health Organization (WHO) with 2.5 million Lampit tablets and additional funding for the distribution of the drug. The latest agreement assures the supply of Lampit until 2012. To widen access of patients to affordable medicines, Bayer HealthCare signed agreements with the World Health Organization (WHO) in 2004 and 2005 for donations of its medicine Lampit (nifurtimox) to combat Chagas disease, the form of sleeping sickness found in Latin America.

Pages